Taketo Kawai

38PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPharmacogenomicsSocio-economic development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Sep 14, 2026
Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance: An Analysis of Nationwide Real-World Data From Japan.

|Sep 06, 2026
Real-World Longitudinal Treatment Outcomes for Patients with Metastatic Castration-Sensitive Prostate Cancer in Japan.

|Aug 27, 2026
Integrating Molecular Classification Based on FGFR3, KRAS, HRAS, and TP53 Mutation With TNM Staging Modestly Improves Prediction of Prognosis of Upper Tract Urothelial Carcinoma After Surgery.

|Jul 09, 2026
Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world study.

|Jun 17, 2026
High Sensitivity ctDNA Analysis Using a Novel Panel and NOIR-SS Technology for Monitoring Advanced Urothelial Carcinoma.

|May 18, 2026
Concurrent Bladder Urothelial Carcinoma and Prostate Tuberculosis: A Case Report.

Pageof 7

Frequent Collaborators

17 joint publications

Satoru Taguchi

7 joint publications

Tomoyuki Kaneko

7 joint publications

Haruki Kume

6 joint publications

Yuta Yamada